Skip to content
Medical Health Aged Care

Community turns out in force to support people impacted by dementia

Dementia Australia 2 mins read

Thank you to the Bendigo community members who turned up in force to the 2024 Memory Walk & Jog, showing their support for Australians living with dementia. More than 400 people walked, ran and jogged on Saturday 20 April raising an impressive $50,000.

 

Dementia Australia CEO Maree McCabe AM said it was a wonderful occasion and extended her gratitude to all who participated, raised funds, spread the word and donated.

 

“There was an outstanding show of support from the Bendigo community who turned out in such large numbers for another year. So many people impacted by dementia find these events a great way to connect with others in similar circumstances. It is such an important day and your support means the world,” Ms McCabe said.

 

Ms McCabe also acknowledged everyone who volunteered at the Bendigo Memory Walk & Jog.

“It is only through the hard work of our wonderful volunteers that the success of this event is possible.”

The Bendigo event is one of the 22 scheduled Memory Walk & Jogs taking place across Australia in 2024. Details on the remaining events in the series can be found at www.memorywalk.com.au

Dementia Australia is encouraging anyone unable to participate at one of our 22 events to consider organising their own group or individual walk or jog, with a MyWay event. More details can be found at www.memorywalk.com.au/get-involved/mw.

 

Walk or jog with us. We are in this together.

 

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

 

-Ends-

Media contacts: Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, ash.blakemore@dementia.org.au. Andrea Hogan, Media and Communications Manager, 0406 904 118, andrea.hogan@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.